Genes differentially expressed in breast cancer
A polynucleotide sequence as shown in SEQ ID NO:1 is associated with metastatic potential of cancer cells, especially breast cancer cells. Methods are provided for determining the risk of metastasis of a tumor, by determining whether a tissue sample from a tumor expresses a polypeptide or mRNA encoded by a polynucleotide as shown in SEQ ID NO:1. Also provided are therapeutic methods and compositions.
1. An isolated polypeptide comprising amino acids selected from the group consisting of:
(a) amino acids about 1 to about 273 of SEQ ID NO:2;
(b) amino acids about 2 to about 273 of SEQ ID NO:2; and
(c) amino acids 26 to 273 of SEQ ID NO:2.
2. An epitope-bearing portion of the polypeptide of SEQ ID NO:2, which comprises at least 200 contiguous amino acids of SEQ ID NO:2.
3. The isolated polypeptide of claim 1 comprising amino acids about 1 to about 273 of SEQ ID NO:2.
4. The isolated polypeptide of claim 1 comprising amino acids about 2 to about 273 of SEQ ID NO:2.
5. The isolated polypeptide of claim 1 comprising amino acids 26 to 273 of SEQ ID NO:2.